Tuesday, April, 23, 2024 05:48:48
Category: Biotechnology
Aimmune Therapeutics Inc., a California-based clinical-stage biopharmaceutical company, has reportedly announced that it has closed the $98 million equity investment by Nestlé Health Science. Reports cite, Nestlé Health Science bought about 3,237,529 newly issued shares of the Brisbane, California-headquartered Aimmune Therapeutics’ common stock, at a …
Canadian biopharmaceutical company, Quest PharmaTech Inc., has reportedly announced its entry into a license agreement with OncoCare Therapeutics Inc., a biopharmaceutical company based in Omaha, Nebraska. According to sources, the duo has come together in a bid to develop and commercialize the targeted cancer therapy …
The Ministry of Science and Technology has recently announced that India and the United Kingdom have both signed a Memorandum of Understanding (MoU) for collaborating on cancer research at the Inaugural Researchers’ Conference in New Delhi. The India-UK Cancer Research Initiative focused on developing affordable …
The tezepelumab therapy produced by pharmaceutical giants AstraZeneca and Amgen, has reportedly won the status of being a ‘breakthrough therapy’ in the United States owing to its potential to cure severe asthma, that too without the eosinophilic phenotype. According to sources familiar with the development, …
Researchers at the University of Colorado Boulder have reportedly developed an unconventional genetic disruption strategy that successfully stymies the growth of antibiotic-resistant bacteria, giving scientists an edge over deadly superbugs. According to data from the Centers for Disease Control, these multiple drug resistant pathogens — …
